Biliary Complications After Liver Transplantation From Uncontrolled Donors After Circulatory Death: Incidence, Management, and Outcome
- 28 September 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 26 (1) , 80-91
Abstract
The utilization of livers from donation after uncontrolled circulatory death (uDCD) increases the availability of liver grafts, but it is associated with a higher incidence of biliary complications (BCs) and lower graft survival than those organs donated after brain death. From January 2006 to December 2016, we performed 75 orthotopic liver transplantations (OLTs) using uDCD livers. To investigate the relationship of BCs with the use of uDCD OLT, we compared patients who developed BCs (23 patients) with those who did not (non‐BC group, 43 patients) after excluding cases of hepatic artery thrombosis (a known cause of BC) and primary nonfunction. The groups had similar uDCD donor maintenance, donor and recipient characteristics, and perioperative morbidity/mortality rates, but we observed a higher rate of hepatocellular carcinoma and hepatitis C virus in the non‐BC group. Percutaneous transhepatic biliary dilation, endoscopic retrograde cholangiopancreatography dilation, Roux‐en‐Y hepaticojejunostomy (HJ), a T‐tube, and retransplantation were used for BC management. In the BC group, 1‐, 3‐, and 5‐year patient survival rates were 91.3%, 69.6%, and 65.2%, respectively, versus 77.8%, 72.9%, and 72.9%, respectively, in the non‐BC group (P = 0.89). However, 1‐, 3‐, and 5‐year graft survival rates were 78.3%, 60.9%, and 56.5%, respectively, in the BC group versus 77.8%, 72.9%, and 72.9%, respectively, in the non‐BC group (P = 0.38). Multivariate analysis did not indicate independent risk factors for BC development. In conclusion, patient and graft survival rates were generally lower in patients who developed BCs but not significantly so. These complications were managed in the majority of patients through radiological dilation, endoscopic dilation, or Roux‐en‐Y HJ. Retransplantation is necessary in rare cases after the failure of biliary dilation or surgical procedures.Keywords
This publication has 46 references indexed in Scilit:
- Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantationJournal of Hepatology, 2019
- Interpreting Outcomes in DCDD Liver TransplantationTransplantation, 2017
- Liver Transplantation Using Grafts From Donors After Circulatory Death: A Propensity Score–Matched Study From a Single CenterAmerican Journal of Transplantation, 2016
- Outcomes Using Grafts from Donors after Cardiac DeathJournal of the American College of Surgeons, 2015
- Using old liver grafts for liver transplantation: Where are the limits?World Journal of Gastroenterology, 2014
- Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefitLiver Transplantation, 2012
- Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation After Cardiac Death DonorsLiver Transplantation, 2011
- Similar liver transplantation survival with selected cardiac death donors and brain death donorsBritish Journal of Surgery, 2010
- The utility of marginal donors in liver transplantationLiver Transplantation, 2003
- Selecting the Donor Liver: Risk Factors for Poor Function After Orthotopic Liver TransplantationHepatology, 1994